Editas Medicine SEC Filings
NASDAQ: EDITHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.90+0.06 (+2.11%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Editas Medicine filing overview
This page lists 1 recent SEC filings by Editas Medicine (EDIT), including 1 8-K. The latest current report (8-K), used to disclose material events such as earnings releases and executive changes, was filed on Oct 8, 2026. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
EDIT SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Oct 8, 2026 | 8-K | Regulation FD Disclosure; Other Events | View on EDGAR |